+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06954597

Evaluating the Safety and Effects of Topical TOP-N53 on Fingertip Ulcers in Systemic Sclerosis Patients Compared to Placebo

Led by Topadur Pharma AG · Updated on 2026-10-01

15

Participants Needed

6

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This clinical trial studies people aged 18 to 69 who have systemic sclerosis with digital ulcers on their fingertips. The trial aims to evaluate the safety of a new drug, TOP-N53, applied directly to these open wounds and to assess if different strengths of the drug can improve symptoms like blood flow, itch, pain, redness, bruising, and bleeding. The study also allows participants to continue a stable dose of Sildenafil 20 mg as part of their treatment. Participants will receive one or two applications of either a placebo or different doses of TOP-N53 solution applied topically to their fingertip ulcers. The drug doses increase sequentially, with higher doses given only after safety with lower doses is confirmed. Treatments involve exposure times of 3 to 24 hours. The study compares these treatments to a placebo solution to assess effects on the ulcers and illness. During the study, participants will attend up to 8 visits over a maximum of 31 days, including up to 2 telephone visits. Doctors will monitor safety by asking questions and examining the wounds before and after treatment. Participants will also complete diaries about symptoms such as pain and itch. Various clinical assessments will measure changes in ulcer appearance and symptoms. The trial tracks adverse events up to 37 days after treatment to understand the safety and tolerability of TOP-N53.

CONDITIONS

Brief Title

Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis

Research Team

C

Claudia Berger, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here